Lifibrol is a cholesterol synthesis inhibitor. Lifibrol enhances the low density lipoprotein apolipoprotein B-100 turnover in patients with hypercholesterolemia and mixed hyperlipidemia.

96609-16-4

C21H26O4

342.43

U-83860;K12148;U 83860;K-12148;K-12.148

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years